5XE Stock Overview
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Extendicare Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$4.82 |
| 52 Week High | CA$5.35 |
| 52 Week Low | CA$3.84 |
| Beta | 1.22 |
| 1 Month Change | -4.55% |
| 3 Month Change | 2.12% |
| 1 Year Change | 12.09% |
| 3 Year Change | -2.82% |
| 5 Year Change | -6.95% |
| Change since IPO | -12.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5XE | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | -2.5% |
| 1Y | 12.1% | -3.8% | -0.4% |
Return vs Industry: 5XE exceeded the German Healthcare industry which returned -3.8% over the past year.
Return vs Market: 5XE exceeded the German Market which returned -0.4% over the past year.
Price Volatility
| 5XE volatility | |
|---|---|
| 5XE Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5XE has not had significant price volatility in the past 3 months.
Volatility Over Time: 5XE's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | n/a | Michael Guerriere | www.extendicare.com |
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.
Extendicare Inc. Fundamentals Summary
| 5XE fundamental statistics | |
|---|---|
| Market cap | €414.80m |
| Earnings (TTM) | €23.19m |
| Revenue (TTM) | €890.48m |
17.8x
P/E Ratio0.5x
P/S RatioIs 5XE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5XE income statement (TTM) | |
|---|---|
| Revenue | CA$1.30b |
| Cost of Revenue | CA$1.14b |
| Gross Profit | CA$167.62m |
| Other Expenses | CA$133.64m |
| Earnings | CA$33.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 0.41 |
| Gross Margin | 12.85% |
| Net Profit Margin | 2.60% |
| Debt/Equity Ratio | 320.8% |
How did 5XE perform over the long term?
See historical performance and comparison